Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) does about 82.75K shares in volume on a normal day but saw 4011339 shares change hands in the recent trading day. The company now has a market cap of 18.22M USD. Its current market price is $1.24, marking an increase of 0.40% compared to the previous close of $1.24. The 52 week high reached by this stock is $2.36 whilst the lowest price level in 52 weeks is $1.04.
Cumberland Pharmaceuticals Inc (CPIX) has a 20-day trading average at $1.1853 and the current price is -47.43% off the 52-week high compared with 19.23% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.2148 and its 200-day simple moving average is $1.4693. If we look at the stock’s price movements over the week, volatility stands at 10.18%, which decreases to 9.93% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 53.41 to suggest the stock is neutral.
The consensus objective for the share price is $9.75, suggesting that the stock has a potential upside of 87.28% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on November 12, 2012 when UBS reiterated the stock to “Neutral” and issued a price target of between $6.50 and $5. UBS downgraded its price target at $10-$8.
The current price level is 4.62%, 2.07%, and -15.61% away from its SMA20, SMA50, and SMA200 respectively, with the CPIX price moving below the 50-day SMA on current market day. Cumberland Pharmaceuticals Inc (CPIX) stock is down -4.62% over the week and 3.33% over the past month. Its price is -30.79% year-to-date and -24.85% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at 0 and 0 for whole year.
To reach the target analysts have set, the stock logically needs to grow 87.28 percent from here.
Outstanding shares total 14.01M with insiders holding 44.80% of the shares and institutional holders owning 14.69% of the company’s common stock. The company has a return on investment of -27.25% and return on equity of -35.76%. The beta has a value of 0.29. Price to book ratio is 0.70 and price to sales ratio is 0.50.
